Lotus Pharm vs Medigen Biotechnology: monthly revenue

Monthly revenue and year-on-year change for Lotus Pharm (1795) and Medigen Biotechnology (3176) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ Lotus Pharm ━ Medigen Biotechnology

0%+226%-68%25/1026/0126/0426/0726/10

Monthly revenue history

MonthLotus PharmYoYMedigen BiotechnologyYoY
Oct 2026NT$2.13 billion-22.5%NT$151.5 million+6.6%
Sep 2026NT$2.77 billion+128.0%NT$255.2 million+49.6%
Aug 2026NT$2.11 billion+81.7%NT$329.2 million+197.4%
Jul 2026NT$2.49 billion+3.9%NT$96.4 million-16.4%
Jun 2026NT$3.4 billion+225.5%NT$94.8 million-30.0%
May 2026NT$2.32 billion+105.8%NT$95.5 million-19.8%
Apr 2026NT$3.09 billion+19.9%NT$94.4 million-10.3%
Mar 2026NT$4.35 billion+173.6%NT$100.5 million-67.9%
Feb 2026NT$2.24 billion+131.5%NT$67.7 million-24.0%
Jan 2026NT$2.05 billion-5.5%NT$93.3 million-4.0%
Dec 2025NT$2.44 billion+66.9%NT$94.5 million-11.1%
Nov 2025NT$1.06 billion-0.2%NT$90 million-17.2%
Oct 2025NT$2.75 billion+46.0%NT$142.1 million+22.9%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16